AstraZeneca Sues Pharmacy Over “Bait And Switch” Tactic With Popular Asthma Drug

Law360, New York (September 6, 2005, 12:00 AM EDT) -- AstraZeneca has sued a manufacturer for trademark infringement and false advertising under the Lanham Act, alleging a copycat version of its inhaled asthma medication Pulmicort Respules is forced on unsuspecting customers.

Connecticut-based Broncho-Dose is a mail order “repertory pharmacy” that allegedly engages in the “often abused practice” of pre-mixing its own non-FDA-approved drugs, according to the complaint. Broncho then distributes the drugs as substitutes for various products, including the product in this suit.

Delaware-based AstraZeneca does not allege the Broncho version of the medication is too...
To view the full article, register now.